Similarly, apigenin sensitized lung cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by increasing the protein levels of the TRAIL receptor (DR5) and reducing the expression of c-FLIP through AS rewiring. Here, TNFSF10 is linked to lung carcinoma.